Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site

Siraj M Ali1, David M Sabatini

  • 1Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology, Department of Biology, Cambridge, 02142, USA.

Insights

The mechanistic target of rapamycin (mTOR) pathway regulates cell growth. This study shows distinct mTOR complexes, raptor-mTOR and rictor-mTOR, differentially phosphorylate S6 kinase 1 (S6K1), clarifying mTOR signaling.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The mechanistic target of rapamycin (mTOR) is a key regulator of cell growth.
  • S6 kinase 1 (S6K1) is a well-studied mTOR effector, and its phosphorylation at threonine 389 (Thr389) is a model for mTOR signaling.
  • Rapamycin sensitivity of Thr389 phosphorylation suggests mTOR is the kinase, but rapamycin-resistant S6K1 mutants challenge this.

Purpose of the Study:

  • To investigate the roles of distinct mTOR complexes in S6K1 phosphorylation.
  • To elucidate the mechanisms underlying rapamycin-sensitive and rapamycin-resistant S6K1 phosphorylation.
  • To determine if rictor-mTOR phosphorylates other kinases.

Main Methods:

  • Utilized rapamycin-sensitive and rapamycin-resistant S6K1 mutants.
  • Investigated phosphorylation by raptor-mTOR and rictor-mTOR complexes.
  • Analyzed the role of the carboxyl-terminal domain in rictor-mTOR phosphorylation.

Main Results:

  • The raptor-mTOR complex phosphorylates rapamycin-sensitive S6K1.
  • The rictor-mTOR complex phosphorylates rapamycin-resistant S6K1 mutants.
  • Rictor-mTOR phosphorylation of Thr389 is independent of the TOR signaling motif and requires carboxyl-terminal domain removal.

Conclusions:

  • Distinct mTOR complexes (raptor-mTOR and rictor-mTOR) have specific roles in S6K1 regulation.
  • Rictor-mTOR may phosphorylate hydrophobic motifs in other AGC family kinases.
  • This research clarifies mTOR signaling pathways and their regulation.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...